Clinical research sites feel growing pressure to perform work in a compliant manner while keeping pace with stakeholder information exchange workstreams, but lack the consistent processes to do so.
Spearheaded by disease foundations, the creation of clinical registries is streamlining data collection and driving informed decisions.
Biometric functional services, more than any other, can have a significant impact through the standardization of data collection and management.
Survey uncovers pediatric-patient perspectives on plain language summaries.
Robust data sets which can effectively represent diverse populations are key to driving greater inclusivity in trials.
With universal adoption of health literacy best practices slow going over the years, advocates are redefining the term to encompass much more of what health-related communication requires beyond simply words.
In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.
The potential of PBPK modeling in answering key questions around these drugs.
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Pandemic sparks new long-term plan for success in R&D.
The fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.
Examining the behaviors of clinical trial stakeholders to better understand challenges in patient participation.
Keys to ensuring your clinical trials better reflect your target population.
Data is the heart of clinical trials, so life sciences firms need to integrate their technology to keep data sources and trial portfolios up-to-date and secure.
Webinar Date/Time: Wed, Sep 20, 2023 10:00 AM EDT
Overcoming saturation in the cell therapy landscape.
With an increasing amount of diverse data that must now be collected and analyzed, the industry is faced with increasingly complex studies that present new challenges in data management.
Lessons from six months of conducting clinical trials during the COVID-19 pandemic
Learn how your team can use EHR-to-EDC technology to reduce data monitoring costs, speed up data cleaning timelines, and hit study milestones faster.
Anticipating the need for both virtual and traditional sites during the planning process can provide high ROI for sponsors.
Natural language processing can help simplify protocols of the past, as evidenced by a recent Novartis initiative.
Assessing the benefits of digital adherence monitoring for sites and patients.
With a major wave of post-COVID trial starts on the horizon, the industry’s need to accelerate clinical research through study start-up is intensifying.
By promoting the use of a standardized terminology and coding system, IDMP eliminates inconsistencies in regulatory processes.
Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools.
All stakeholders must play part in increasing implementation.
Improving receptivity and response to the evolving nature of clinical trial patient oversight.
Findings from an OCT Clinical survey of researchers from 61 sites in Russia to gain the perspective of an investigator regarding clinical trials during the COVID-19 pandemic.
Non-profit biotech organization Cure Rare Disease utilizes collaboration amidst COVID-19 pandemic to catalyze speed of therapeutic research.